Last 12 months
Inside the activity.
0 purchase rows · 240 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 200 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 31 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 01, 2020 Filed Sep 2, 2020 21:04 UTC |
Mason Michael BSr. VP & Pres., Lilly Diabetes
|
Tax withholdingCommon Stock | 2,735 | $148.39 | $405,846.65 |
DisclosureSEC source: 0000059478-20-000137 · wf-form4_159908062423990.xml · nonDerivative · entry 2 Mason Michael B · CIK 0001799419 · Sr. VP & Pres., Lilly Diabetes 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,544 Read SEC document |
| September 01, 2020 Filed Sep 2, 2020 21:04 UTC |
Mason Michael BSr. VP & Pres., Lilly Diabetes
|
Exercise / conversionCommon Stock | 6,244 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-20-000137 · wf-form4_159908062423990.xml · nonDerivative · entry 1 Mason Michael B · CIK 0001799419 · Sr. VP & Pres., Lilly Diabetes 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,279 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 17, 2020 Filed Aug 18, 2020 19:28 UTC |
TAI JACKSON PDirector
|
GrantCommon Stock | 13 | $151.53 | $1,969.89 |
DisclosureSEC source: 0000059478-20-000133 · wf-form4_159777887461991.xml · nonDerivative · entry 1 TAI JACKSON P · CIK 0001173275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,301 Read SEC document |
| August 17, 2020 Filed Aug 18, 2020 19:31 UTC |
Fry Stephen FSVP, HR & Diversity
|
SaleCommon Stock | 7,204 | $150.64 | $1,085,210.56 |
DisclosureSEC source: 0000059478-20-000135 · wf-form4_159777905185668.xml · nonDerivative · entry 1 Fry Stephen F · CIK 0001513324 · SVP, HR & Diversity 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,211 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 27, 2020. F2 · price: This transaction was executed in multiple trades at prices ranging from $150.36 to $150.98. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 05, 2020 Filed Feb 2, 2021 22:09 UTC |
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERM
|
GiftCommon Stock | 1,600 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-21-000012 · wf-form5_161230372271295.xml · nonDerivative · entry 1 Barnes Melissa S · CIK 0001566364 · Chief Eth/Cmpl Ofcr & SVP, ERM 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,980 Read SEC document |
| July 20, 2020 Filed Jul 21, 2020 19:54 UTC |
TAI JACKSON PDirector
|
GrantCommon Stock | 12 | $167.04 | $2,004.48 |
DisclosureSEC source: 0000059478-20-000125 · wf-form4_159536122646461.xml · nonDerivative · entry 1 TAI JACKSON P · CIK 0001173275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,288 Read SEC document |
| July 09, 2020 Filed Jul 10, 2020 18:16 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 220 | $170.32 | $37,469.96 |
DisclosureSEC source: 0001209191-20-042136 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,132,343 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $170.31 to $170.40, inclusive. Read SEC document |
| July 09, 2020 Filed Jul 10, 2020 18:16 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 12,741 | $169.68 | $2,161,922.18 |
DisclosureSEC source: 0001209191-20-042136 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,132,563 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $166.20 to $170.11, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| July 09, 2020 Filed Jul 13, 2020 17:43 UTC |
Zulueta Alfonso GSVP & President, Lilly Int'l
|
SaleCommon Stock | 11,000 | $170.00 | $1,870,000.00 |
DisclosureSEC source: 0000059478-20-000123 · wf-form4_159466220506801.xml · nonDerivative · entry 1 Zulueta Alfonso G · CIK 0001596336 · SVP & President, Lilly Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,646 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 6, 2020 and amended on June 11, 2020. Read SEC document |
| July 07, 2020 Filed Jul 8, 2020 16:49 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 44,745 | $167.83 | $7,509,508.61 |
DisclosureSEC source: 0001209191-20-041658 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,145,304 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $167.60 to $168.26, inclusive. Read SEC document |
| July 07, 2020 Filed Jul 8, 2020 16:49 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 165,255 | $167.15 | $27,622,290.62 |
DisclosureSEC source: 0001209191-20-041658 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,190,049 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $166.60 to $167.595, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| July 06, 2020 Filed Jul 7, 2020 18:27 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 24,308 | $168.36 | $4,092,567.80 |
DisclosureSEC source: 0001209191-20-041489 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,655,304 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $168.00 to $168.91, inclusive. Read SEC document |
| July 06, 2020 Filed Jul 7, 2020 18:27 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 65,046 | $167.40 | $10,888,726.42 |
DisclosureSEC source: 0001209191-20-041489 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,379,612 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $167.00 to $167.99, inclusive. Read SEC document |
| July 06, 2020 Filed Jul 7, 2020 18:27 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 115,646 | $166.46 | $19,250,791.66 |
DisclosureSEC source: 0001209191-20-041489 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,444,658 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $166.00 to $166.995, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), and (3) to this Form 4. Read SEC document |
| July 05, 2020 Filed Jul 6, 2020 20:50 UTC |
Pusey Leigh AnnSVP, Corp. Affairs & Comm.
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,468 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-20-000121 · wf-form4_159406859487629.xml · derivative · entry 3 Pusey Leigh Ann · CIK 0001708919 · SVP, Corp. Affairs & Comm. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,468 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. F2 · derivative.exercise_date: The Restricted Stock Units vest in three installments: 2,394 on July 5, 2018; 2,394 on July 5, 2019; and 2,468 on July 5, 2020. F2 · derivative.expiration_date: The Restricted Stock Units vest in three installments: 2,394 on July 5, 2018; 2,394 on July 5, 2019; and 2,468 on July 5, 2020. Read SEC document |
| July 05, 2020 Filed Jul 6, 2020 20:50 UTC |
Pusey Leigh AnnSVP, Corp. Affairs & Comm.
|
Tax withholdingCommon Stock | 1,114 | $163.87 | $182,551.18 |
DisclosureSEC source: 0000059478-20-000121 · wf-form4_159406859487629.xml · nonDerivative · entry 2 Pusey Leigh Ann · CIK 0001708919 · SVP, Corp. Affairs & Comm. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,310 Read SEC document |
| July 05, 2020 Filed Jul 6, 2020 20:50 UTC |
Pusey Leigh AnnSVP, Corp. Affairs & Comm.
|
Exercise / conversionCommon Stock | 2,468 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-20-000121 · wf-form4_159406859487629.xml · nonDerivative · entry 1 Pusey Leigh Ann · CIK 0001708919 · SVP, Corp. Affairs & Comm. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,424 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 30, 2020 Filed Jul 1, 2020 15:17 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 300 | $164.02 | $49,205.10 |
DisclosureSEC source: 0001209191-20-039575 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,560,304 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $164.00 to $164.025, inclusive. Read SEC document |
| June 30, 2020 Filed Jul 1, 2020 15:17 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 166,532 | $163.20 | $27,178,555.30 |
DisclosureSEC source: 0001209191-20-039575 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,560,604 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $163.00 to $163.99, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| June 29, 2020 Filed Jun 30, 2020 19:12 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 608 | $164.04 | $99,736.32 |
DisclosureSEC source: 0001209191-20-039426 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,727,136 Read SEC document |
| June 29, 2020 Filed Jun 30, 2020 19:12 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 10,823 | $163.36 | $1,768,023.63 |
DisclosureSEC source: 0001209191-20-039426 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,727,744 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $163.00 to $163.84, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| June 26, 2020 Filed Jun 30, 2020 18:48 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 31,737 | $163.01 | $5,173,403.94 |
DisclosureSEC source: 0001209191-20-039425 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,738,567 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $163.00 to $164.415, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| June 26, 2020 Filed Jul 1, 2020 13:55 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 31,737 | $163.01 | $5,173,403.94 |
DisclosureSEC source: 0001209191-20-039565 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,738,567 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $163.00 to $164.415, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| June 18, 2020 Filed Jun 19, 2020 18:21 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 2,422 | $162.65 | $393,928.61 |
DisclosureSEC source: 0001209191-20-037851 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,770,304 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $162.53 to $162.85, inclusive. Read SEC document |
| June 18, 2020 Filed Jun 19, 2020 18:21 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 25,544 | $162.10 | $4,140,702.84 |
DisclosureSEC source: 0001209191-20-037851 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,772,726 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $161.52 to $162.50, inclusive. Read SEC document |
| June 18, 2020 Filed Jun 19, 2020 18:21 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 25,804 | $160.88 | $4,151,414.61 |
DisclosureSEC source: 0001209191-20-037851 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,798,270 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $160.50 to $161.49, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), and (3) to this Form 4. Read SEC document |
| June 17, 2020 Filed Jun 18, 2020 21:16 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 16,488 | $163.02 | $2,687,923.22 |
DisclosureSEC source: 0001209191-20-037672 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,824,074 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $162.84 to $163.385, inclusive. Read SEC document |
| June 17, 2020 Filed Jun 18, 2020 21:16 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 31,210 | $162.28 | $5,064,814.98 |
DisclosureSEC source: 0001209191-20-037672 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,840,562 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $161.84 to $162.83, inclusive. Read SEC document |
| June 17, 2020 Filed Jun 18, 2020 21:16 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 113,532 | $160.90 | $18,266,731.14 |
DisclosureSEC source: 0001209191-20-037672 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,871,772 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $160.50 to $161.49, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), and (3) to this Form 4. Read SEC document |
| June 16, 2020 Filed Jun 17, 2020 19:13 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 1,523 | $167.18 | $254,613.62 |
DisclosureSEC source: 0001209191-20-037202 · doc4.xml · nonDerivative · entry 10 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,985,304 F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $167.05 to $167.27, inclusive. Read SEC document |
| June 16, 2020 Filed Jun 17, 2020 19:13 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 14,823 | $166.41 | $2,466,754.72 |
DisclosureSEC source: 0001209191-20-037202 · doc4.xml · nonDerivative · entry 9 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,986,827 F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $166.02 to $166.99, inclusive. Read SEC document |
| June 16, 2020 Filed Jun 17, 2020 19:13 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 15,935 | $165.60 | $2,638,851.94 |
DisclosureSEC source: 0001209191-20-037202 · doc4.xml · nonDerivative · entry 8 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,001,650 F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $165.02 to $166.01, inclusive. Read SEC document |
| June 16, 2020 Filed Jun 17, 2020 19:13 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 19,373 | $164.57 | $3,188,233.98 |
DisclosureSEC source: 0001209191-20-037202 · doc4.xml · nonDerivative · entry 7 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,017,585 F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $164.02 to $165.00, inclusive. Read SEC document |
| June 16, 2020 Filed Jun 17, 2020 19:13 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 56,144 | $163.40 | $9,174,041.89 |
DisclosureSEC source: 0001209191-20-037202 · doc4.xml · nonDerivative · entry 6 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,036,958 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $163.02 to $164.00, inclusive. Read SEC document |
| June 16, 2020 Filed Jun 17, 2020 19:13 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 46,024 | $162.66 | $7,486,033.72 |
DisclosureSEC source: 0001209191-20-037202 · doc4.xml · nonDerivative · entry 5 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,093,102 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $162.02 to $163.01, inclusive. Read SEC document |
| June 16, 2020 Filed Jun 17, 2020 19:13 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 19,290 | $161.46 | $3,114,486.24 |
DisclosureSEC source: 0001209191-20-037202 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,139,126 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $161.00 to $161.99, inclusive. Read SEC document |
| June 16, 2020 Filed Jun 17, 2020 19:13 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 17,850 | $160.35 | $2,862,326.04 |
DisclosureSEC source: 0001209191-20-037202 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,158,416 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $160.00 to $160.98, inclusive. Read SEC document |
| June 16, 2020 Filed Jun 17, 2020 19:13 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 18,466 | $159.57 | $2,946,615.93 |
DisclosureSEC source: 0001209191-20-037202 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,176,266 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $159.00 to $159.99, inclusive. Read SEC document |
| June 16, 2020 Filed Jun 17, 2020 19:13 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 2,909 | $158.54 | $461,186.75 |
DisclosureSEC source: 0001209191-20-037202 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,194,732 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $158.00 to $158.98, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5), (6), (7), (8), (9), and (10) to this Form 4. Read SEC document |
| June 16, 2020 Filed Jun 18, 2020 13:36 UTC |
Zulueta Alfonso GSVP & President, Lilly Int'l
|
SaleCommon Stock | 10,000 | $165.00 | $1,650,000.00 |
DisclosureSEC source: 0000059478-20-000119 · wf-form4_159248735208255.xml · nonDerivative · entry 2 Zulueta Alfonso G · CIK 0001596336 · SVP & President, Lilly Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,646 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 6, 2020 and amended on June 11, 2020. Read SEC document |
| June 16, 2020 Filed Jun 18, 2020 13:36 UTC |
Zulueta Alfonso GSVP & President, Lilly Int'l
|
SaleCommon Stock | 7,000 | $160.00 | $1,120,000.00 |
DisclosureSEC source: 0000059478-20-000119 · wf-form4_159248735208255.xml · nonDerivative · entry 1 Zulueta Alfonso G · CIK 0001596336 · SVP & President, Lilly Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,646 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 6, 2020 and amended on June 11, 2020. Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 20:30 UTC |
TAI JACKSON PDirector
|
GrantCommon Stock | 14 | $141.52 | $1,981.28 |
DisclosureSEC source: 0000059478-20-000115 · wf-form4_159233942488966.xml · nonDerivative · entry 1 TAI JACKSON P · CIK 0001173275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,276 Read SEC document |
| June 05, 2020 Filed Jun 9, 2020 20:52 UTC |
Zulueta Alfonso GSVP & President, Lilly Int'l
|
SaleCommon Stock | 10,000 | $150.00 | $1,500,000.00 |
DisclosureSEC source: 0000059478-20-000112 · wf-form4_159173595632339.xml · nonDerivative · entry 1 Zulueta Alfonso G · CIK 0001596336 · SVP & President, Lilly Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,646 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 6, 2020. Read SEC document |
| May 18, 2020 Filed May 20, 2020 13:08 UTC |
TAI JACKSON PDirector
|
GrantCommon Stock | 12 | $157.96 | $1,895.52 |
DisclosureSEC source: 0000059478-20-000110 · wf-form4_158998011290329.xml · nonDerivative · entry 1 TAI JACKSON P · CIK 0001173275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,200 Read SEC document |
| April 28, 2020 Filed Feb 2, 2021 22:16 UTC |
Norton JohnaSenior VP, Global Quality
|
GiftCommon Stock | 156 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-21-000016 · wf-form5_161230415317974.xml · nonDerivative · entry 1 Norton Johna · CIK 0001702471 · Senior VP, Global Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,518 Read SEC document |
| April 27, 2020 Filed Apr 28, 2020 16:21 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 12,663 | $163.60 | $2,071,714.92 |
DisclosureSEC source: 0001209191-20-025889 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,197,641 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $163.50 to $164.14, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| April 24, 2020 Filed Apr 27, 2020 18:36 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 4,200 | $163.99 | $688,758.00 |
DisclosureSEC source: 0001209191-20-025778 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,210,304 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $163.685 to $164.23, inclusive. Read SEC document |
| April 24, 2020 Filed Apr 27, 2020 18:36 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 118,958 | $163.05 | $19,396,530.15 |
DisclosureSEC source: 0001209191-20-025778 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,214,504 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $162.6721 to $163.67, inclusive. Read SEC document |
| April 24, 2020 Filed Apr 27, 2020 18:36 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 47,225 | $162.18 | $7,658,870.22 |
DisclosureSEC source: 0001209191-20-025778 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,333,462 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $161.67 to $162.66, inclusive. Read SEC document |
| April 24, 2020 Filed Apr 27, 2020 18:36 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 49,617 | $161.22 | $7,999,059.23 |
DisclosureSEC source: 0001209191-20-025778 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,380,687 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $160.67 to $161.66, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3) and (4) to this Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.